Meloxicam Injectable Solution Rapid Onset
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current meloxicam formulations, particularly injectable forms, face challenges due to poor solubility, leading to delayed onset of action, instability, and increased manufacturing costs. There is a need for stable, rapid-acting, and cost-effective injectable meloxicam solutions for human use.
Innovation Solution
Development of novel injectable meloxicam solutions that are ready-to-use or ready-to-dilute, using solubilizers like meglumine and cyclodextrin derivatives, and stabilizers to enhance solubility and stability, allowing for intravenous administration with rapid onset of action.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If meloxicam is formulated as oral tablets for approval and marketing, then the drug can be manufactured and distributed, but the onset of action is delayed due to poor water solubility and prolonged absorption
Solution Approach 1:
The patent changes the physical state of meloxicam from solid tablets to liquid injectable form, and modifies the molecular environment by adding solubilizers and stabilizers. This transforms the drug delivery parameters to achieve rapid onset of action while maintaining therapeutic efficacy
Solution Approach 2:
The patent introduces intermediary substances including solubilizers (to enhance water solubility), stabilizers (to prevent degradation), and other excipients that facilitate the dissolution and stability of meloxicam in injectable form, enabling rapid parenteral administration
2Speed
If meloxicam is formulated as injectable dispersion to improve onset of action, then rapid pain relief can be achieved, but manufacturing complexity and costs increase due to poor solubility characteristics
Solution Approach 1:
The patent changes the physical state from solid dispersion to liquid solution and modifies chemical parameters by incorporating solubilizers and stabilizers, simplifying the manufacturing process while achieving rapid onset of action through parenteral administration
Solution Approach 2:
The patent creates a composite injectable formulation combining meloxicam with solubilizers, stabilizers, and other excipients in a liquid medium, achieving both rapid onset of action and manufacturing feasibility through a unified composition
3Loss of time
If meloxicam is formulated as injectable solution to achieve rapid onset of action, then acute pain management is improved, but formulation stability becomes challenging due to poor solubility
Solution Approach 1:
The patent introduces stabilizers as intermediary substances that prevent degradation of meloxicam in injectable form, and solubilizers that enhance water solubility, thereby achieving both rapid onset of action and formulation stability
Solution Approach 2:
The patent modifies the chemical environment by adding stabilizers and solubilizers, changing the physical state to liquid injectable form, and optimizing pH and other parameters to achieve both rapid onset of action and long-term formulation stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solutions provide stable, rapid-acting, and cost-effective meloxicam formulations that overcome the limitations of current products, offering faster pain relief and improved manufacturing efficiency.
Implementation Method 1
The stability of the solution is dependent on the pH of the solution and the presence of stabilizers and/or solubilizers such as meglumine
Implementation Method 2
using solubilizers like meglumine and cyclodextrin derivatives
Data Source
AI summary
The present invention relates to stable injectable compositions comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, wherein the composition is provided in a sealed container, e.g., an ampoule, vial and pre-filled syringe. Further, the present invention relates to a stable injectable solution comprising meloxicam or its pharmaceutically acceptable salts, solvates, or hydrates thereof, suitable for subcutaneous, intravenous or intramuscular administration. The invention relates to methods for manufacturing stable injectable solutions of meloxicam. The present invention further relates to a method of treating pain by parenterally administering to a patient in need thereof a composition comprising a stable solution of meloxicam, wherein said solution provides rapid onset of action for pain relief compared to a reference composition.